Vincent Segers
Vincent Segers
Verified email at
Cited by
Cited by
Stem-cell therapy for cardiac disease
VFM Segers, RT Lee
Nature 451 (7181), 937-942, 2008
Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury
PCH Hsieh, VFM Segers, ME Davis, C MacGillivray, J Gannon, ...
Nature medicine 13 (8), 970-974, 2007
Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction
VFM Segers, T Tokunou, LJ Higgins, C MacGillivray, J Gannon, RT Lee
Circulation 116 (15), 1683-1692, 2007
Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms
VFM Segers, I Van Riet, LJ Andries, K Lemmens, MJ Demolder, ...
American Journal of Physiology-Heart and Circulatory Physiology 290 (4 …, 2006
Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction
ME Padin-Iruegas, Y Misao, ME Davis, VFM Segers, G Esposito, ...
Circulation 120 (10), 876-887, 2009
Role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte cross-talk
K Lemmens, VFM Segers, M Demolder, GW De Keulenaer
Journal of biological chemistry 281 (28), 19469-19477, 2006
Biomaterials to enhance stem cell function in the heart
VFM Segers, RT Lee
Circulation research 109 (8), 910-922, 2011
Local delivery of proteins and the use of self-assembling peptides
VFM Segers, RT Lee
Drug discovery today 12 (13-14), 561-568, 2007
Protein therapeutics for cardiac regeneration after myocardial infarction
VFM Segers, RT Lee
Journal of cardiovascular translational research 3 (5), 469-477, 2010
The continuous heart failure spectrum: moving beyond an ejection fraction classification
F Triposkiadis, J Butler, FM Abboud, PW Armstrong, S Adamopoulos, ...
European heart journal 40 (26), 2155-2163, 2019
Cardiac endothelium–myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction
SL Lim, CSP Lam, VFM Segers, DL Brutsaert, GW De Keulenaer
European heart journal 36 (31), 2050-2060, 2015
Stromal cell-derived factor-1 retention and cardioprotection for ischemic myocardium
S Kanki, VFM Segers, W Wu, R Kakkar, J Gannon, SU Sys, ...
Circulation: Heart Failure 4 (4), 509-518, 2011
Cardiac remodeling: endothelial cells have more to say than just NO
VFM Segers, DL Brutsaert, GW De Keulenaer
Frontiers in physiology 9, 382, 2018
Protease-resistant stromal cell–derived factor-1 for the treatment of experimental peripheral artery disease
VFM Segers, V Revin, W Wu, H Qiu, Z Yan, RT Lee, A Sandrasagra
Circulation 123 (12), 1306-1315, 2011
Self‐assembling peptide nanofibers and skeletal myoblast transplantation in infarcted myocardium
G Dubois, VFM Segers, V Bellamy, L Sabbah, S Peyrard, P Bruneval, ...
Journal of Biomedical Materials Research Part B: Applied Biomaterials: An …, 2008
Engineering insulin‐like growth factor‐1 for local delivery
T Tokunou, R Miller, P Patwari, ME Davis, VFM Segers, AJ Grodzinsky, ...
The FASEB Journal 22 (6), 1886-1893, 2008
ErbB2 signaling at the crossing between heart failure and cancer
Z Vermeulen, VFM Segers, GW De Keulenaer
Basic research in cardiology 111 (6), 1-14, 2016
Inhibitory actions of the NRG-1/ErbB4 pathway in macrophages during tissue fibrosis in the heart, skin, and lung
Z Vermeulen, AS Hervent, L Dugaucquier, L Vandekerckhove, ...
American Journal of Physiology-Heart and Circulatory Physiology 313 (5 …, 2017
Heart failure with preserved ejection fraction: a review of cardiac and noncardiac pathophysiology
AB Gevaert, JRA Boen, VF Segers, EM Van Craenenbroeck
Frontiers in physiology 10, 638, 2019
Pulmonary hypertension and right heart failure in heart failure with preserved left ventricular ejection fraction: pathophysiology and natural history
VFM Segers, DL Brutsaert, GW De Keulenaer
Current opinion in cardiology 27 (3), 273-280, 2012
The system can't perform the operation now. Try again later.
Articles 1–20